Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bittium Oyj Director's Dealing 2022

Oct 25, 2022

3258_rns_2022-10-25_4ed203da-7a00-45ec-9a20-ffdb55c32184.html

Director's Dealing

Open in viewer

Opens in your device viewer

Bittium Corporation: Notification of Manager's Transactions - Riitta Tiuraniemi

Bittium Corporation: Notification of Manager's Transactions - Riitta Tiuraniemi

Stock exchange release

Free for publication on October 25, 2022, at 12:45 (CEST+1)

Bittium Corporation: Notification of Manager's Transactions - Riitta Tiuraniemi

Person subject to the notification requirement

Name: Riitta Tiuraniemi

Position: Member of the Board/Deputy member

Issuer: Bittium Corporation

LEI: 743700NFG5W5I59OVX65

Notification type: INITIAL NOTIFICATION

Reference number: 20552/5/4

Transaction date: 2022-10-24

Venue: NASDAQ HELSINKI LTD (XHEL)

Instrument type: SHARE

ISIN: FI0009007264

Nature of the transaction: ACQUISITION

(X) Executed under portfolio or asset management

Transaction details

(1): Volume: 2314 Unit price: 3.7664 EUR

(2): Volume: 1681 Unit price: 3.7512 EUR

Aggregated transactions

(2): Volume: 3995 Volume weighted average price: 3.76 EUR

Oulu, Finland, October 25, 2022

Bittium Corporation

Further information

Kari Jokela
CLO
Tel. +358 40 344 5258

Distribution

Nasdaq Helsinki Oy
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and
connectivity solutions leveraging its over 35-year legacy of expertise in
advanced radio communication technologies. Bittium provides innovative products
and services, customized solutions based on its product platforms and R&D
services. Complementing its communications and connectivity solutions, Bittium
offers proven information security solutions for mobile devices and portable
computers. Bittium also provides healthcare technology products and services for
biosignal measuring in the areas of cardiology and neurophysiology. Net sales in
2021 were EUR 86.9 million and operating profit was EUR 3.2 million. Bittium is
listed on Nasdaq Helsinki. www.bittium.com

Attachments: